Summary: We recently published a piece on the importance of temperature in C.elegans which got the whole InVivio Biosystems team thinking about C. elegans’ development, and how it can best be compared. As a result, we thought it would be fun to take pictures of C. elegans in the three most commonly used temperatures to …
Temperature & C. elegans Part Two: How does Temperature affect development? Read More »
In this white paper we will discuss the advantages and limitations of zebrafish and ask: is a zebrafish model right for my research?
In this whitepaper we discuss the advantages and limitations of C. elegans, and ask the question: is a C. elegans model right for my research?
In this article we discuss the rise in gut dysbiosis, and new risk factors: microplastics, consumption of supplements, and chronic stress.
In this article, we will discuss the commonly used model organisms for microbiome research, and what insights they can provide.
Summary A recent publication by Crouzier et al. emphasized the utility of zebrafish as a model for investigating rare diseases — enabling better understanding of their underlying mechanisms, and the development of therapeutics to treat these diseases. In this article we will discuss Crouzier et al.’s publication, and InVivo Biosystems’ ongoing work to help identify …
Review of Zebrafish Models to Boost Research in Rare Genetic Diseases Read More »
This article will discuss recent findings, and how similar studies present an exciting and promising future for currently incurable diseases.
Summary Zebrafish models largely began as a way to research developmental biology, however, their potential to be a preclinical model of human disease quickly became apparent. While the pharmaceutical industry initially invested in zebrafish models, they have yet to widely adopt it – it’s time for that to change. George Stresinger began using zebrafish as …
Lost and Found: Zebrafish as a Drug Discovery Tool Read More »
In this article we discuss Weissbourd’s recent publication as well as GCaMP more broadly, showing how advancing technology has enabled researchers to ask questions that span disciplines and model organism species.
Beyond research into vaccines and traditional therapeutics, the medical community is exploring other ways of helping to prevent, and reduce, symptoms of COVID-19. One promising supplement is a common probiotic. In this article we will discuss the studies that have been conducted, their findings, and answer the question: who could benefit from taking probiotics?
